SHP2 overexpression is commonly observed in HER2 (+) ERα⁄PR (+) infiltrating ductal carcinoma, and the elevated level of SHP2 protein in breast cancer is positively correlated with lymph node metastasis and higher tumor grade (23). This evidence concerns the gene PTPN11 and breast carcinoma.